Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1940 1
1947 1
1963 2
1964 3
1965 2
1966 2
1967 3
1970 5
1971 1
1972 4
1973 1
1974 2
1976 3
1978 1
1979 3
1980 5
1981 5
1982 2
1983 3
1984 2
1985 4
1986 4
1987 3
1988 3
1989 2
1990 3
1991 1
1992 5
1993 4
1994 12
1995 3
1996 7
1997 17
1998 9
1999 10
2000 5
2001 9
2002 8
2003 11
2004 8
2005 16
2006 17
2007 12
2008 19
2009 15
2010 11
2011 10
2012 9
2013 13
2014 7
2015 22
2016 17
2017 13
2018 14
2019 12
2020 5
2021 8
2022 7
2023 7
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D; KEYNOTE-048 Investigators. Burtness B, et al. Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1. Lancet. 2019. PMID: 31679945 Clinical Trial.
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.
Tamura K, Tsurutani J, Takahashi S, Iwata H, Krop IE, Redfern C, Sagara Y, Doi T, Park H, Murthy RK, Redman RA, Jikoh T, Lee C, Sugihara M, Shahidi J, Yver A, Modi S. Tamura K, et al. Among authors: redman ra. Lancet Oncol. 2019 Jun;20(6):816-826. doi: 10.1016/S1470-2045(19)30097-X. Epub 2019 Apr 29. Lancet Oncol. 2019. PMID: 31047803 Clinical Trial.
Salivary gland carbonic anhydrases.
Redman RS. Redman RS. Histol Histopathol. 2025 Nov;40(11):1675-1692. doi: 10.14670/HH-18-917. Epub 2025 Apr 4. Histol Histopathol. 2025. PMID: 40270308 Review.
Street outreach triptych.
Redman R. Redman R. Fam Syst Health. 2020 Mar;38(1):91. doi: 10.1037/fsh0000461. Fam Syst Health. 2020. PMID: 32202838
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial.
Harrington KJ, Ferris RL, Gillison M, Tahara M, Argiris A, Fayette J, Schenker M, Bratland Å, Walker JWT, Grell P, Even C, Chung CH, Redman R, Coutte A, Salas S, Grant C, de Azevedo S, Soulières D, Hansen AR, Wei L, Khan TA, Miller-Moslin K, Roberts M, Haddad R. Harrington KJ, et al. Among authors: redman r. JAMA Oncol. 2023 Jun 1;9(6):779-789. doi: 10.1001/jamaoncol.2023.0147. JAMA Oncol. 2023. PMID: 37022706 Free PMC article.
CHROMOSOMAL ABNORMALITIES AND ORAL ANOMALIES.
GORLIN RJ, REDMAN RS. GORLIN RJ, et al. Among authors: redman rs. Am J Surg. 1964 Sep;108:370-9. doi: 10.1016/0002-9610(64)90354-x. Am J Surg. 1964. PMID: 14215118 Review. No abstract available.
Myoepithelium of salivary glands.
Redman RS. Redman RS. Microsc Res Tech. 1994 Jan 1;27(1):25-45. doi: 10.1002/jemt.1070270103. Microsc Res Tech. 1994. PMID: 8155903 Review.
Fungal endophytes: diversity and functional roles.
Rodriguez RJ, White JF Jr, Arnold AE, Redman RS. Rodriguez RJ, et al. Among authors: redman rs. New Phytol. 2009;182(2):314-330. doi: 10.1111/j.1469-8137.2009.02773.x. Epub 2009 Feb 19. New Phytol. 2009. PMID: 19236579 Free article. Review.
An Improved P(V) Thio-Oligonucleotide Synthesis Platform.
Nassir M, Gherardi L, Redman RL, Jin Y, Yao F, Yang Y, Raheja N, Natarajan A, Butler D, Knouse KW, Baran PS. Nassir M, et al. Among authors: redman rl. Org Lett. 2025 Jan 10;27(1):97-102. doi: 10.1021/acs.orglett.4c03980. Epub 2024 Dec 19. Org Lett. 2025. PMID: 39700460
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Ferris RL MD,, Leidner RS, Chung CH, Jimeno A, Lee SM, Sukari A, Nieva JJ, Grilley-Olson JE, Redman R, Wong SJ, Villaflor VM, Misleh J, Finckenstein FG, Chou J, Gastman B, Fiaz R, Catlett M, Yi M, Cohen EEW. Ferris RL MD,, et al. Among authors: redman r. J Immunother Cancer. 2025 Aug 24;13(8):e011633. doi: 10.1136/jitc-2025-011633. J Immunother Cancer. 2025. PMID: 40854613 Free PMC article. Clinical Trial.
393 results